QELZINTIK Trademark

Trademark Overview


On Wednesday, April 30, 2025, a trademark application was filed for QELZINTIK with the United States Patent and Trademark Office. The USPTO has given the QELZINTIK trademark a serial number of 99164427. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Wednesday, October 1, 2025. This trademark is owned by Merck Sharp & Dohme B.V.. The QELZINTIK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
qelzintik

General Information


Serial Number99164427
Word MarkQELZINTIK
Filing DateWednesday, April 30, 2025
Status802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
Status DateWednesday, October 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 30, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck Sharp & Dohme B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHAARLEM 2031BN
NL

Party NameMerck Sharp & Dohme B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHAARLEM 2031BN
NL

Trademark Events


Event DateEvent Description
Wednesday, April 30, 2025NEW APPLICATION ENTERED
Wednesday, April 30, 2025APPLICATION FILING RECEIPT MAILED
Friday, July 18, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 18, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, July 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 21, 2025ASSIGNED TO EXAMINER
Friday, July 25, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 2, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 2, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 1, 2025EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 18, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED